Gazelle Study

Enroll Now

Type of Study:

An interventional randomized trial to demonstrate the equivalence in the safety and efficacy profile between MYL-1601D and ovoLog® in volunteers with T1DM.

Title of Study:

Mylan insulin Aspart trial in Volunteers with Type 1 Diabetes Basal/ Bolus Insulin Users

Short Title:

The Gazelle Study

Study Length: 7 months

Target Age/Sex: 18 – 65 years of age Male and Female


Participants will receive at no cost: study product, study materials and study-specific procedures


Live better, healthier, smarter

Schedule an Appointment